{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T16:22:03Z","timestamp":1792686123291,"version":"4.5.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T00:00:00Z","timestamp":1781913600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular and Cellular Probes"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.mcp.2026.102078","type":"journal-article","created":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T15:08:52Z","timestamp":1781968132000},"page":"102078","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["The CXCL9\u2013CXCR3 axis mediates tumor progression and immune checkpoint regulation in colorectal cancer"],"prefix":"10.1016","volume":"89","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-1272-767X","authenticated-orcid":false,"given":"Yuan","family":"Yuan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhang","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song","family":"Yucheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.mcp.2026.102078_bib1","first-page":"576","article-title":"Colorectal cancer: risk factors, novel approaches in molecular screening and treatment","volume":"14","author":"Anbari","year":"2025","journal-title":"Int. J. Mol. Cellul. Med."},{"key":"10.1016\/j.mcp.2026.102078_bib2","first-page":"1","article-title":"Novel methods of personalized treatment in colorectal cancer: a literature review","volume":"9","author":"Khan","year":"2025","journal-title":"Undergrad. Res. Nat. Clin. Sci. Technol. J."},{"key":"10.1016\/j.mcp.2026.102078_bib3","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2025.1591059","article-title":"Global research landscape of antiangiogenic therapy for colorectal cancer: a bibliometric analysis of mechanistic insights and clinical advancements","volume":"15","author":"Hou","year":"2025","journal-title":"Front. Oncol."},{"issue":"12","key":"10.1016\/j.mcp.2026.102078_bib4","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1038\/s41568-025-00872-1","article-title":"The immune microenvironment of colorectal cancer","volume":"25","author":"Kennel","year":"2025","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.mcp.2026.102078_bib5","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/s41392-024-01953-7","article-title":"Signaling pathways involved in colorectal cancer: pathogenesis and targeted therapy","volume":"9","author":"Li","year":"2024","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.mcp.2026.102078_bib6","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1717666","article-title":"Chemokines in the resolution of inflammation: key players and targets for therapeutic modulation","volume":"16","author":"Oliveira","year":"2025","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.mcp.2026.102078_bib7","doi-asserted-by":"crossref","first-page":"H927","DOI":"10.1152\/ajpheart.00675.2025","article-title":"Periostin contributes to differential sex-linked gene expression during infarct healing","volume":"330","author":"Abual\u2019anaz","year":"2026","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"2","key":"10.1016\/j.mcp.2026.102078_bib8","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1002\/JLB.5MR0320-205R","article-title":"Tumor inhibition or tumor promotion? The duplicity of CXCR3 in cancer","volume":"108","author":"Russo","year":"2020","journal-title":"J. Leucocyt. Biol."},{"key":"10.1016\/j.mcp.2026.102078_bib9","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.882017","article-title":"Evolution, expression and functional analysis of CXCR3 in neuronal and cardiovascular diseases: a narrative review","volume":"10","author":"Satarkar","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.mcp.2026.102078_bib10","article-title":"NK cell immune responses in viral infections and cancer","author":"Momayyezi","year":"2026","journal-title":"Karolinska Inst."},{"key":"10.1016\/j.mcp.2026.102078_bib11","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1601773","article-title":"Tumor-infiltrating lymphocytes in cancer immunotherapy: from chemotactic recruitment to translational modeling","volume":"16","author":"Kraja","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.mcp.2026.102078_bib12","article-title":"Critical role of reproductive tract microbiota and derived metabolites in inflammation, tumor immunity, and tumorigenesis of gynecological cancers: a narrative review","volume":"17","author":"Chen","year":"2026","journal-title":"Front. Immunol."},{"issue":"8","key":"10.1016\/j.mcp.2026.102078_bib13","doi-asserted-by":"crossref","first-page":"3455","DOI":"10.3390\/ijms27083455","article-title":"A literature review of interleukins in the development and treatment of breast cancer","volume":"27","author":"Kra\u015bnicka","year":"2026","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.mcp.2026.102078_bib14","article-title":"Xiaoyao San alleviates emotional distress-induced TNBC growth through augmenting intratumoral CD8+ T cell infiltration mediated by Rela\/NF-kB-Cxcl9 axis","volume":"17","author":"Liang","year":"2026","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.mcp.2026.102078_bib15","doi-asserted-by":"crossref","DOI":"10.1080\/15384047.2025.2538962","article-title":"Dual role of CXCL10 in cancer progression: implications for immunotherapy and targeted treatment","volume":"26","author":"Madkhali","year":"2025","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.mcp.2026.102078_bib16","article-title":"Targeting cellular source-specific CXCL9 signaling for immunotherapy in oral squamous cell carcinoma","volume":"17","author":"Qiu","year":"2026","journal-title":"Front. Immunol."},{"key":"10.1016\/j.mcp.2026.102078_bib17","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1404768","article-title":"Chemokine family significance and prognostic value in colorectal cancer","volume":"15","author":"Ding","year":"2025","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.mcp.2026.102078_bib18","doi-asserted-by":"crossref","first-page":"335","DOI":"10.3390\/ph15030335","article-title":"Revolutionization in cancer therapeutics via targeting major immune checkpoints PD-1, PD-L1 and CTLA-4","volume":"15","author":"Pandey","year":"2022","journal-title":"Pharmaceuticals"},{"issue":"6","key":"10.1016\/j.mcp.2026.102078_bib19","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.3390\/ijms27062693","article-title":"The significance of CXCL1 in cancer: an overview of molecular mechanisms","volume":"27","author":"Korbecki","year":"2026","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.mcp.2026.102078_bib20","article-title":"CXCR2P1 enhances the response of gastric cancer to PD-1 inhibitors through increasing the immune infiltration of tumors","volume":"16","author":"Wu","year":"2025","journal-title":"Front. Immunol."},{"issue":"11","key":"10.1016\/j.mcp.2026.102078_bib21","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1038\/s41417-024-00811-6","article-title":"NF-\u03baB role on tumor proliferation, migration, invasion and immune escape","volume":"31","author":"Khan","year":"2024","journal-title":"Cancer Gene Ther."},{"issue":"5","key":"10.1016\/j.mcp.2026.102078_bib22","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1002\/ijc.70132","article-title":"Chemotherapy as a double\u2010edged sword: modulation of tumor\u2010associated cytokine and chemokine responses in ovarian cancer","volume":"158","author":"Ullah","year":"2026","journal-title":"Int. J. Cancer"},{"issue":"1","key":"10.1016\/j.mcp.2026.102078_bib23","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/s41392-026-02583-x","article-title":"Reactive oxygen species (ROS) in cancer: from mechanism to therapeutic implications","volume":"11","author":"Akter","year":"2026","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.mcp.2026.102078_bib24","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1452212","article-title":"PD-1 and CTLA-4 serve as major gatekeepers for effector and cytotoxic T cell potentiation by limiting a CXCL9\/10-CXCR3-IFN\u03b3 positive feedback loop","volume":"15","author":"Abdala-Saleh","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.mcp.2026.102078_bib25","article-title":"Macrophage-derived chemokines in T cell regulation: implications for cancer immunotherapy","volume":"16","author":"Zhang","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.mcp.2026.102078_bib26","article-title":"Current status and future prospects of molecular imaging in targeting the tumor immune microenvironment","volume":"16","author":"Wang","year":"2025","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.mcp.2026.102078_bib27","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/s12943-025-02305-x","article-title":"Advances in cancer immunotherapy: historical perspectives, current developments, and future directions","volume":"24","author":"Zhang","year":"2025","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.mcp.2026.102078_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/imm.70103","article-title":"Bidirectional regulation in the tumour microenvironment: the interaction between tumour-associated macrophages and T cells reshapes the paradigm of cancer immunotherapy","volume":"178","author":"Li","year":"2026","journal-title":"Immunology"},{"issue":"6","key":"10.1016\/j.mcp.2026.102078_bib29","doi-asserted-by":"crossref","first-page":"536","DOI":"10.3390\/cells15060536","article-title":"ChemoNETosis in cancer: a comprehensive review of treatment-induced NET formation and therapeutic consequences","volume":"15","author":"Stojanovic","year":"2026","journal-title":"Cells"},{"issue":"5","key":"10.1016\/j.mcp.2026.102078_bib30","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2018.1424672","article-title":"Prognosis of ovarian cancer is associated with effector memory CD8+ T cell accumulation in ascites, CXCL9 levels and activation-triggered signal transduction in T cells","volume":"7","author":"Lieber","year":"2018","journal-title":"Oncoimmunology"},{"issue":"1","key":"10.1016\/j.mcp.2026.102078_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/15384101.2025.2599081","article-title":"Dysregulation of the cyclin D\/E2F activity as a core mechanism driving cancer stem cell plasticity and cell cycle dynamics","volume":"25","author":"Ahmadi","year":"2026","journal-title":"Cell Cycle"},{"issue":"3","key":"10.1016\/j.mcp.2026.102078_bib32","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.3390\/ijms27031228","article-title":"Cyclin D1\/D2\u2013CDK4 drives cell migration by orchestrating cytoskeletal dynamics through a TGF\u03b2\u2013FAK\u2013Rac1 axis","volume":"27","author":"Guo","year":"2026","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.mcp.2026.102078_bib33","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2174\/1566524022666211222161637","article-title":"Free radicals and oxidative stress: signaling mechanisms, redox basis for human diseases, and cell cycle regulation","volume":"23","author":"Sadiq","year":"2023","journal-title":"Curr. Mol. Med."},{"issue":"7","key":"10.1016\/j.mcp.2026.102078_bib34","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.70268","article-title":"Oxidative stress: signaling pathways, biological functions, and disease","volume":"6","author":"Liu","year":"2025","journal-title":"MedComm"},{"key":"10.1016\/j.mcp.2026.102078_bib35","doi-asserted-by":"crossref","DOI":"10.2174\/0118715206402131251015065042","article-title":"An updated insight into the phytomolecules reported for the treatment of Colon cancer from 2015 to 2024","author":"Nooreen","year":"2026","journal-title":"Anti Cancer Agents Med. Chem."},{"key":"10.1016\/j.mcp.2026.102078_bib36","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1383456","article-title":"Targeting PD-1\/PD-L-1 immune checkpoint inhibition for cancer immunotherapy: success and challenges","volume":"15","author":"Javed","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.mcp.2026.102078_bib37","article-title":"PD-1\/PD-L1 checkpoint inhibitors in tumor immunotherapy","volume":"12","author":"Liu","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.mcp.2026.102078_bib38","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s40659-025-00597-3","article-title":"Recent advances in the mechanisms of PD-L1 expression in gastric cancer: a review","volume":"58","author":"Chen","year":"2025","journal-title":"Biol. Res."},{"issue":"1","key":"10.1016\/j.mcp.2026.102078_bib39","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s13045-020-01027-5","article-title":"Regulation of PD-L1 expression in the tumor microenvironment","volume":"14","author":"Yi","year":"2021","journal-title":"J. Hematol. Oncol."}],"container-title":["Molecular and Cellular Probes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890850826000186?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890850826000186?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T23:55:37Z","timestamp":1786751737000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0890850826000186"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":39,"alternative-id":["S0890850826000186"],"URL":"https:\/\/doi.org\/10.1016\/j.mcp.2026.102078","relation":{},"ISSN":["0890-8508"],"issn-type":[{"value":"0890-8508","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The CXCL9\u2013CXCR3 axis mediates tumor progression and immune checkpoint regulation in colorectal cancer","name":"articletitle","label":"Article Title"},{"value":"Molecular and Cellular Probes","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mcp.2026.102078","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102078"}}